Holen Sie sich die Stockscreener-App
2.04
0.49%
-0.010
Handel nachbörslich:
2.06
0.02
+0.98%
Schlusskurs vom Vortag:
$2.05
Offen:
$2.05
24-Stunden-Volumen:
110.09K
Relative Volume:
0.87
Marktkapitalisierung:
$204.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.14M
KGV:
-2.8753
EPS:
-0.7095
Netto-Cashflow:
$-68.17M
1W Leistung:
-5.12%
1M Leistung:
-13.19%
6M Leistung:
-20.00%
1J Leistung:
-36.84%
1-Tages-Spanne:
$2.03
$2.065
1-Wochen-Bereich:
$2.03
$2.1892
52-Wochen-Spanne:
$1.4299
$3.98
Ac Immune Sa Stock (ACIU) Company Profile
Vergleichen Sie ACIU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.04 | 206.23M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-31 | Eingeleitet | BTIG Research | Buy |
| 2019-02-01 | Herabstufung | UBS | Buy → Neutral |
| 2019-01-04 | Eingeleitet | UBS | Buy |
| 2018-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | Eingeleitet | Credit Suisse | Outperform |
| 2016-10-18 | Eingeleitet | Jefferies | Buy |
| 2016-10-18 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Ac Immune Sa Aktie (ACIU) Neueste Nachrichten
AC Immune SA stock trendline breakdownWeekly Risk Report & Verified Entry Point Signals - Newser
Risk adjusted return profile for AC Immune SA analyzedWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
Published on: 2025-08-30 15:00:47 - Newser
Analyzing net buyer seller activity in AC Immune SAEarnings Miss & Fast Gain Stock Trading Tips - Newser
Can you recover from losses in AC Immune SA2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Will AC Immune SA bounce back from current support2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Visual analytics tools that track AC Immune SA performance2025 Trading Volume Trends & Weekly High Return Stock Opportunities - Newser
Price action breakdown for AC Immune SAWeekly Profit Analysis & High Return Stock Watch Alerts - Newser
Using data models to predict AC Immune SA stock movementJuly 2025 Macro Moves & High Return Trade Opportunity Guides - Newser
Order flow analysis tools used on AC Immune SAMarket Rally & Long-Term Growth Stock Strategies - Newser
Analyzing drawdowns of AC Immune SA with statistical tools2025 Performance Recap & Consistent Income Trade Ideas - Newser
Forecasting AC Immune SA price range with options data2025 Technical Overview & Safe Entry Zone Identification - Newser
Ranking AC Immune SA among high performing stocks via toolsForecast Cut & Real-Time Volume Spike Alerts - Newser
Will AC Immune SA benefit from macro trends2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Advanced analytics toolkit walkthrough for AC Immune SATrade Exit Summary & Safe Capital Growth Tips - Newser
Chart based exit strategy for AC Immune SA2025 Key Lessons & Weekly Top Gainers Trade List - Newser
When is the best time to exit AC Immune SAJuly 2025 Pullbacks & Pattern Based Trade Signal System - Newser
What is AC Immune SA s debt to equity ratioJuly 2025 Volume & Daily Chart Pattern Signals - sundaytimes.kr
Using portfolio simulators with AC Immune SA includedSell Signal & High Yield Stock Recommendations - Newser
What’s the recovery path for long term holders of AC Immune SA2025 Price Targets & Community Consensus Picks - Newser
Will AC Immune SA continue its uptrendPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Backtesting results for AC Immune SA trading strategies2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Identifying reversal signals in AC Immune SAJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Finanzdaten der Ac Immune Sa-Aktie (ACIU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):